Abstract

Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product

Author(s): Chauhan Nikita N, Patel Jayvadan K

Issue: Jan/Feb 2023 - Volume 27, Number 1

Page(s): 60-71

Download in electronic PDF format for $75
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 1
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 2
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 3
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 4
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 5
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 6
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 7
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 8
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 9
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 10
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 11
  • Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product Page 12

Abstract

The objective of this study was to prepare and evaluate ibuprofen nanocrystals using isopropyl alcohol and stabilizer sodium lauryl sulphate by way of the precipitation method. The nanocrystals were prepared by the bottom-up approach of the precipitation technique. This technique involves the use of an organic phase, which is completely miscible in the external aqueous phase. The ratio used for organic solvent-to-aqueous solvent was 1:50. The Fourier Transform Infrared Spectroscopy analyses confirmed that the drug and excipients were compatible, and the differential scanning calorimetry results indicated that the precipitation method led to no change in the crystalline structure of the drug. Scanning electron microscopy analysis of ibuprofen nanocrystals showed the promising size reduction of pure drug ibuprofen. Differential light scattering technique showed significant decrease in particle size and good stability of ibuprofen nanocrystals. Ibuprofen nanocrystals increased 20% to 25% of the saturation solubility of ibuprofen nanocrystals. Ibuprofen nanocrystals showed 90% drug release in the dissolution medium within 1 hour, while the pure drug and market product were dissolved only up to 58% and 63%, respectively. Ibuprofen nanocrystals increased the saturation solubility and in vitro dissolution of the drug as compared to conventional market product.

Related Keywords

  • ibuprofen nanocrystals
  • precipitation method
  • commercial ibuprofen
  • drug release
  • nonsteroidal anti-inflammatory drugs
  • NSAID
  • cyclooxygenase
  • aqueous solubility
  • solubility in water
  • drug absorption
  • bioavailability
  • drug dissolution
  • saturation solubility
  • stability testing
  • disintegration test
  • particle size
  • zeta potential
  • particle size reduction

Related Categories

  • PAIN MANAGEMENT
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2023
Pg. 60-71
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Author(s): Chauhan Nikita N, Patel Jayvadan K
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
May/Jun 2020
Pg. 227
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 320
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Author(s): Allen Loyd V Jr
May/Jun 2011
Pg. 245
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Author(s): Allen Loyd V Jr
Jan/Feb 2023
Pg. 72-77
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Author(s): Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
May/Jun 2011
Pg. 244
Ibuprofen 5% Topical Cream
Author(s): Allen Loyd V Jr
Jan/Feb 2011
Pg. 66
Ibuprofen 5% Gel
Author(s): Allen Loyd V Jr
Jan/Feb 2013
Pg. 67
Ibuprofen 10-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Sep/Oct 2023
Pg. 431-439
The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Author(s): Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Nov/Dec 2023
Pg. 474-481
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 292-293
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 146-155
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Sep/Oct 2017
Pg. 418-425
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2004
Pg. 388
Ibuprofen 2% Topical Gel
Author(s): Allen Loyd V Jr
Jan/Feb 2000
Pg. 36-38
Marketing Your Prescription Compounding Practice: Part One
Author(s): Letendre William R, Jackson Richard A
Jul/Aug 2023
Pg. 340-346
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Sep/Oct 2021
Pg. 364-371
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Author(s): Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
Jan/Feb 2003
Pg. 44-45
Determining the Availability of a Commercial Drug
Author(s):